Overview

Adelphi Real World provides real world evidence by running Disease Specific Programmes (DSPs), tailored non-interventional studies, and international secondary database analyses to generate insights from physicians, patients, caregivers, and payers. Its work collects data across Europe, the USA, Asia, and Latin America to inform activities across the brand lifecycle, including health outcomes, medical affairs, market access, and marketing communications. The company combines DSPs and Bespoke solutions to deliver end-to-end evidence that covers the full lifecycle of a medical product and helps shape both multi-country strategies and domestic execution. Its goal is to provide actionable real-world evidence that supports decision-making and improves outcomes throughout a product’s lifecycle.